Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Medtronic plcSHS(MDT) | 2,750,000 | 2,750,000 | 0 | $247.6K | $219.7K | 8.59% | -$27.9K |
| Viatris Inc.(VTRS) | 15,000,000 | 15,000,000 | 0 | $174.2K | $186.8K | 7.30% | +$12.6K |
| Zimmer Biomet Holdings, Inc.(ZBH) | 2,500,000 | 1,605,000 | -895,000 | $269.9K | $169.5K | 6.63% | -$100.3K |
| Humana Inc.(HUM) | 200,000 | 650,000 | +450,000 | $63.3K | $164.9K | 6.45% | +$101.6K |
| PTC Therapeutics, Inc.(PTCT) | 3,500,000 | 3,200,000 | -300,000 | $129.8K | $144.4K | 5.65% | +$14.6K |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,150,000 | 1,150,000 | 0 | $128.1K | $141.6K | 5.54% | +$13.5K |
| Baxter Intl Inc | 6,500,000 | 4,625,000 | -1,875,000 | $246.8K | $134.9K | 5.28% | -$111.9K |
| CVS Health Corporation(CVS) | 1,500,000 | 3,000,000 | +1,500,000 | $94.3K | $134.7K | 5.27% | +$40.4K |
| Pfizer Inc.(PFE) | 0 | 5,000,000 | +5,000,000 | $0 | $132.7K | 5.19% | +$132.7K |
| Sarepta Therapeutics, Inc.(SRPT) | 775,000 | 1,000,000 | +225,000 | $96.8K | $121.6K | 4.76% | +$24.8K |
| Ascendis Pharma A/SADR(ASND) | 700,000 | 800,000 | +100,000 | $104.5K | $110.1K | 4.31% | +$5.6K |
| Globus Medical, Inc.CL A(GMED) | 2,150,000 | 1,225,000 | -925,000 | $153.8K | $101.3K | 3.96% | -$52.5K |
| GSK plcADR(GSK) | 3,000,000 | 2,500,000 | -500,000 | $122.6K | $84.5K | 3.31% | -$38.1K |
| Brookdale Senior Living Inc.(BKD) | 13,935,000 | 13,935,000 | 0 | $94.6K | $70.1K | 2.74% | -$24.5K |
| Concentra Group Holdings Parent, Inc.(CON) | 1,975,000 | 3,500,000 | +1,525,000 | $44.2K | $69.2K | 2.71% | +$25.1K |
| Qiagen N.V.SHS NEW(QGEN) | 1,500,000 | 1,500,000 | 0 | $68.4K | $66.8K | 2.61% | -$1.6K |
| Denali Therapeutics Inc.(DNLI) | 2,000,000 | 2,250,000 | +250,000 | $58.3K | $45.9K | 1.79% | -$12.4K |
| Evolent Health, Inc.CL A(EVH) | 1,400,000 | 4,000,000 | +2,600,000 | $39.6K | $45.0K | 1.76% | +$5.4K |
| Alkermes plcSHS(ALKS) | 200,000 | 1,500,000 | +1,300,000 | $5.6K | $43.1K | 1.69% | +$37.5K |
| Myriad Genetics, Inc.(MYGN) | 3,950,000 | 3,100,000 | -850,000 | $108.2K | $42.5K | 1.66% | -$65.7K |
| Medpace Holdings, Inc.(MEDP) | 125,000 | 125,000 | 0 | $41.7K | $41.5K | 1.62% | -$196 |
| The Cigna Group(CI) | 0 | 150,000 | +150,000 | $0 | $41.4K | 1.62% | +$41.4K |
| Zimvie Inc | 2,725,000 | 2,725,000 | 0 | $43.2K | $38.0K | 1.49% | -$5.2K |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 450,000 | +450,000 | $0 | $29.6K | 1.16% | +$29.6K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 441,000 | 441,000 | 0 | $22.2K | $23.9K | 0.93% | +$1.6K |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 625,000 | +625,000 | $0 | $21.9K | 0.85% | +$21.9K |
| Herbalife Ltd.(HLF) | 3,000,000 | 3,000,000 | 0 | $21.6K | $20.1K | 0.79% | -$1.5K |
| Inogen, Inc.(INGN) | 2,000,000 | 2,000,000 | 0 | $19.4K | $18.3K | 0.72% | -$1.1K |
| Brookdale Senior Living Inc.UNIT 11 15 2025(BKD) | 250,000 | 250,000 | 0 | $23.1K | $17.2K | 0.67% | -$5.8K |
| Anaptysbio Inc | 0 | 1,250,000 | +1,250,000 | $0 | $16.6K | 0.65% | +$16.6K |
| OraSure Technologies, Inc.(OSUR) | 4,250,000 | 4,250,000 | 0 | $18.1K | $15.3K | 0.60% | -$2.8K |
| 10x Genomics, Inc.CL A(TXG) | 0 | 1,000,000 | +1,000,000 | $0 | $14.4K | 0.56% | +$14.4K |
| Merus N V | 0 | 250,000 | +250,000 | $0 | $10.5K | 0.41% | +$10.5K |
| Theravance Biopharma Inc | 1,000,000 | 1,000,000 | 0 | $8.1K | $9.4K | 0.37% | +$1.4K |
| Structure Therapeutics IncADS | 0 | 300,000 | +300,000 | $0 | $8.1K | 0.32% | +$8.1K |
| Genmab A/SADS(GMAB) | 50,000 | 50,000 | 0 | $1.2K | $1.0K | 0.04% | -$175 |
| Bicycle Therapeutics PlcADS | 915,000 | 0 | -915,000 | $20.7K | $0 | — | -$20.7K |
| Select Med Hldgs Corp | 2,125,000 | 0 | -2,125,000 | $74.1K | $0 | — | -$74.1K |
| SkinHealth Systems Inc.CL A(SKIN) | 1,500,000 | 0 | -1,500,000 | $2.2K | $0 | — | -$2.2K |
| Universal Health Services, Inc.CL B(UHS) | 125,000 | 0 | -125,000 | $28.6K | $0 | — | -$28.6K |